Fiche du document
22 mai 2024
- doi: 10.1021/acscentsci.4c00054
- issn: 2374-7943
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1021/acscentsci.4c00054
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/38799657
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2374-7943
Ce document est lié à :
info:eu-repo/grantAgreement/SNF//CRSII5_180323///
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D699DFB0BBF25
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
ARMs Mortgage loans, Variable rate Renegotiable rate mortgage loans Graduated payment mortgage loans Variable rate mortgage loans Antivirals Antiviral drugsCiter ce document
Y. Zhu et al., « Benzene with Alkyl Chains Is a Universal Scaffold for Multivalent Virucidal Antivirals. », Serveur académique Lausannois, ID : 10.1021/acscentsci.4c00054
Métriques
Partage / Export
Résumé
Most viruses start their invasion by binding to glycoproteins' moieties on the cell surface (heparan sulfate proteoglycans [HSPG] or sialic acid [SA]). Antivirals mimicking these moieties multivalently are known as broad-spectrum multivalent entry inhibitors (MEI). Due to their reversible mechanism, efficacy is lost when concentrations fall below an inhibitory threshold. To overcome this limitation, we modify MEIs with hydrophobic arms rendering the inhibitory mechanism irreversible, i.e., preventing the efficacy loss upon dilution. However, all our HSPG-mimicking MEIs only showed reversible inhibition against HSPG-binding SARS-CoV-2. Here, we present a systematic investigation of a series of small molecules, all containing a core and multiple hydrophobic arms terminated with HSPG-mimicking moieties. We identify the ones that have irreversible inhibition against all viruses including SARS-CoV-2 and discuss their design principles. We show efficacy in vivo against SARS-CoV-2 in a Syrian hamster model through both intranasal instillation and aerosol inhalation in a therapeutic setting (12 h postinfection). We also show the utility of the presented design rules in producing SA-mimicking MEIs with irreversible inhibition against SA-binding influenza viruses.
